Guide to Diagnostic Tests
- amikacin
- amitriptyline
- braf
- carbamazepine
- clinical use of pharmacogenetic testing
- cyclosporine
- cyp 2c19 variants
- cystic fibrosis transmembrane conductance regulator (cftr)
- cytochrome p450 (cyp) 2c9 variants
- desipramine
- digoxin
- dpd variants
- ethosuximide
- genetic influences on therapeutic drug response
- gentamicin
- her2
- hla-b*1502 allele
- hla-b*5801 allele
- hla-b*b5701 allele
- imipramine
- indications for drug monitoring
- k-ras
- lidocaine
- lithium
- methotrexate
- nortriptyline
- other information required for effective drug monitoring
- pharmacokinetic parameters
- phenobarbital
- phenytoin
- sirolimus
- situations in which drug monitoring may not be useful
- tacrolimus
- theophylline
- thiopurine methyltransferase (tpmt) variants
- tobramycin
- underlying assumptions
- uridine diphosphoglucuronosyltransferase 1a1 (ugt 1a1) variants
- valproic acid (valproate), total
- vancomycin
- vitamin k epoxide reductase complex (vkorc1) variants